¼¼°èÀÇ mRNA ÇÕ¼º ¹× Á¦Á¶ ½ÃÀå ¿¹Ãø(-2029³â) : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ¼­ºñ½ºº°, Áö¿ªº°
mRNA Synthesis & Manufacturing Market by Product (Consumables [Transcription, Purification, Analysis & Characterization], Instrument), Service (Synthesis, Purification, Manufacturing & Scale-up), Application (CGT, Vaccines) - Global Forecast to 2029
»óǰÄÚµå : 1678870
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 351 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,162,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,621,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,792,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

mRNA ÇÕ¼º¡¤Á¦Á¶ ½ÃÀå ±Ô¸ð´Â 2024³â 6¾ï 2,440¸¸ ´Þ·¯¿¡¼­ 2029³â¿¡´Â 7¾ï 3,830¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 3.4%¿¡ ´ÞÇÒ °ÍÀ¸·Î º¸À̰í ÀÖ½À´Ï´Ù.

mRNA Ä¡·áÁ¦´Â Àç»ýÀÇÇп¡¼­ Á¶Á÷ º¹±¸¸¦ À§ÇÑ Â÷¼¼´ë ¾à¹°·Î À¯¸ÁÇÑ °ÍÀ¸·Î Æò°¡¹Þ°í ÀÖ½À´Ï´Ù. ºñ¸é¿ª¿ø¼º mRNAÀÇ °³¹ßÀº ¾ÈÀü¼º°ú È¿´ÉÀ» Çâ»ó½ÃŰ´Â º¯ÇüµÈ ´ºÅ¬·¹¿À½Ãµå¸¦ »ç¿ëÇÏ¿© ´Þ¼ºÇÒ ¼ö ÀÖÀ¸¸ç, mRNAÀÇ ±¸Á¶¸¦ º¯È­½ÃÅ´À¸·Î½á ¿¬±¸ÀÚµéÀº in vitro Àü»ç¸¦ ÅëÇØ ¾ÈÁ¤ÀûÀÎ ºñ¸é¿ª¿ø¼º mRNA¸¦ »ý¼ºÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ mRNA¿¡ ƯȭµÈ È¿°úÀûÀÎ Àü´Þ Àü·«Àº ÀÌ·¯ÇÑ Ä¡·á¹ýÀÇ ¹ßÀü¿¡ ÇʼöÀûÀÔ´Ï´Ù. »ýü Àç·á¿¡¼­ mRNA¸¦ ÀûÀçÇÏ°í ¹æÃâÇÏ´Â °úÁ¤Àº Á¶Á÷ º¹±¸¿¡ Àû¿ëÇϱâ À§ÇØ ÇʼöÀûÀ̸ç, ±× ÀáÀç·ÂÀ» ±Ø´ëÈ­Çϱâ À§Çؼ­´Â ´õ ¸¹Àº °³¼±ÀÌ ÇÊ¿äÇÕ´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó¿¬µµ 2022-2029³â
±âÁØ¿¬µµ 2023³â
¿¹Ãø ±â°£ 2024-2029³â
°ËÅä ´ÜÀ§ ±Ý¾×(100¸¸ ´Þ·¯)
ºÎ¹®º° Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ¼­ºñ½ºº°, Áö¿ªº°
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦Ç°º°·Î mRNA ÇÕ¼º ¹× Á¦Á¶ ½ÃÀåÀº ¼Ò¸ðǰ, Àåºñ·Î ±¸ºÐµÇ¸ç, ¼Ò¸ðǰ ºÎ¹®Àº 2023³â mRNA ÇÕ¼º ¹× Á¦Á¶ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ ºÎ¹®Àº ´Ù½Ã Àü»ç ¼Ò¸ðǰ, Á¤Á¦ ¼Ò¸ðǰ, ºÐ¼® ¹× Ư¼ºÈ­ ¼Ò¸ðǰÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù. ¼Ò¸ðǰ ºÎ¹®ÀÌ ¿¹Ãø ±â°£ Áß ¿ìÀ§¸¦ Á¡ÇÏ´Â ÀÌÀ¯´Â mRNA ÇÕ¼º ¹× Á¦Á¶¿¡ ÇʼöÀûÀÎ ¼Ò¸ðǰÀÌ ÀÏȸ¼º ÅõÀÚÀÎ Àåºñ¿Í ´Þ¸® ¼Ò¸ðǰÀº ÁÖ±âÀûÀ¸·Î º¸ÃæÇØ¾ß ÇϹǷΠÁö¼ÓÀûÀÎ ¼ö¿ä°¡ ¹ß»ýÇϱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ Àüü ½ÃÀåÀº ÁÖ·Î Thermo Fisher Scientific Inc.(¹Ì±¹), Sartorius AG(µ¶ÀÏ)°¡ Á¦°øÇÏ´Â Àåºñ¿¡ ÀÇÇØ ¿î¿µµÇ°í ÀÖÁö¸¸, mRNA ÇÕ¼º ¹× Á¦Á¶¸¦ À§ÇÑ ¼Ò¸ðǰ ºÐ¾ß¿¡¼­´Â ´õ ¸¹Àº ±â¾÷ÀÌ È°µ¿Çϰí ÀÖ½À´Ï´Ù.

¼­ºñ½ºº°·Î mRNA ÇÕ¼º ¹× Á¦Á¶ ½ÃÀåÀº mRNA ÇÕ¼º ¹× º¯Çü, mRNA Á¤Á¦, mRNA ºÐ¼® ¹× Ư¼ºÈ­, Á¦Á¶ ¹× ½ºÄÉÀϾ÷À¸·Î ±¸ºÐµÇ¸ç, 2023³â mRNA ÇÕ¼º ¹× Á¦Á¶ ½ÃÀå¿¡¼­ mRNA ÇÕ¼º ¹× º¯Çü ºÐ¾ß°¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. mRNA ÇÕ¼º ¹× º¯Çü ¼­ºñ½ºÀÇ Áß¿äÇÑ ÃËÁø¿äÀÎÀº Ä¡·áÁ¦ ¹× ¹é½Å Èĺ¸¹°ÁúÀÇ È¿´É°ú ¾ÈÁ¤¼ºÀ» ³ôÀ̱â À§ÇØ ¸ÂÃãÇü mRNA ¼­¿­ ¹× º¯ÇüÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, À̸¦ À§Çؼ­´Â Àü¹®ÀûÀÎ ÇÕ¼º ¹× º¯Çü ¼­ºñ½º°¡ ÇÊ¿äÇÏ´Ù´Â Á¡ÀÔ´Ï´Ù. ¿¬±¸ÀÚ ¹× °³¹ßÀÚµéÀº ´Ü¹éÁú ¹ßÇö °³¼±, ¸é¿ª ¹ÝÀÀ °­È­ µî ƯÁ¤ Ä¡·á È¿°ú¿¡ ÃÖÀûÈ­ÇÒ ¼ö ÀÖ´Â ¸ÂÃãÇü mRNA ¼­¿­À» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº Àü ¼¼°è mRNA ÇÕ¼º ¹× Á¦Á¶ ½ÃÀå¿¡¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀÔ´Ï´Ù. ÀÇ·áºñ Áõ°¡, Àεµ, Áß±¹, ÀϺ» µî ÁÖ¿ä ½ÃÀå¿¡¼­ÀÇ ¿¬±¸°³¹ß È®´ë, ³·Àº ÀΰǺñ, ¾çÈ£ÇÑ ±ÔÁ¦ ȯ°æ µîÀÇ ¿äÀÎÀÌ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹ÀÇ mRNA ÇÕ¼º ¹× Á¦Á¶ ½ÃÀåÀº ¹ÙÀÌ¿À ±â¼ú Çõ½Å¿¡ ´ëÇÑ Á¤ºÎÀÇ ¸·´ëÇÑ ÅõÀÚ, ±¹³» ¹ÙÀÌ¿À ±â¼ú ÀÎÇÁ¶óÀÇ ±Þ¼ÓÇÑ È®Àå, ±¹Á¦ Çù·Â °ü°è Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù Áß±¹Àº mRNA ±â¼ú ¹ßÀü¿¡ ´ëÇÑ °­ÇÑ ÀÇÁö¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ mRNA ÇÕ¼º¡¤Á¦Á¶ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ¼­ºñ½ºº°, Áö¿ªº° µ¿Çâ ¹× ½ÃÀå¿¡ Âü¿©ÇÏ´Â ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ÁÖ¿ä ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå mRNA ÇÕ¼º¡¤Á¦Á¶ ½ÃÀå(Á¦Ç°º°)

Á¦7Àå mRNA ÇÕ¼º¡¤Á¦Á¶ Á¦Ç° ½ÃÀå(¿ëµµº°)

Á¦8Àå mRNA ÇÕ¼º¡¤Á¦Á¶ Á¦Ç° ½ÃÀå(ÃÖÁ¾»ç¿ëÀÚº°)

Á¦9Àå mRNA ÇÕ¼º¡¤Á¦Á¶ ½ÃÀå(¼­ºñ½ºº°)

Á¦10Àå mRNA ÇÕ¼º¡¤Á¦Á¶ ¼­ºñ½º ½ÃÀå(ÃÖÁ¾»ç¿ëÀÚº°)

Á¦11Àå mRNA ÇÕ¼º¡¤Á¦Á¶ ½ÃÀå(Áö¿ªº°)

Á¦13Àå ±â¾÷ °³¿ä

Á¦14Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The mRNA synthesis and manufacturing market is expected to reach USD 738.3 million in 2029 from USD 624.4 million in 2024, at a CAGR of 3.4% during the forecast period. mRNA therapeutics hold promise as the next generation of drugs for tissue restoration in regenerative medicine. The development of non-immunogenic mRNA can be achieved through the use of modified nucleosides, which enhances safety and efficacy. By altering the mRNA structure, researchers can create stable, non-immunogenic mRNA through in vitro transcription. Furthermore, effective delivery strategies tailored specifically for mRNA are crucial for the advancement of these therapies. The processes involved in loading and releasing mRNA from biomaterials are essential for their application in tissue restoration and require further refinement to maximize their potential.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million)
SegmentsBy Product, Application, Service, and End Users
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

"The transcription consumables segment accounted for the largest share by product segment in the mRNA synthesis and manufacturing market in 2023."

Based on product, the mRNA synthesis and manufacturing market is segmented into consumables, and instrument. In 2023, the consumables segment accounted for the largest share of mRNA synthesis and manufacturing market; this segment is further segmented into transcription consumables, purification consumables, and analysis & characterization consumables. Dominance of the consumables segment throughout the forecast period is attributed to the fact that they are essential for mRNA synthesis and manufacturing. Unlike instruments, which are a one-time investment, consumables must be replenished regularly, leading to continuous demand. Also, the entire market operates majorly on instruments offered by Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), whereas more companies operate in the consumables space for mRNA synthesis and manufacturing.

"The mRNA synthesis & modification service segment is expected to grow at the highest growth rate in the mRNA synthesis and manufacturing market throughout the forecast period."

Based on service, the mRNA synthesis and manufacturing market is segmented into mRNA synthesis & modification, mRNA purification, mRNA analysis & characterization, and manufacturing & scale-up. In 2023, the mRNA synthesis & modification segment accounted for the largest share of the mRNA synthesis and manufacturing market. A significant driver for the mRNA synthesis and modification services within the mRNA synthesis and manufacturing market is the growing need for customized mRNA sequences and modifications to enhance the efficacy and stability of therapeutic and vaccine candidates, which requires specialized synthesis and modification services. As the application of mRNA technology expands, researchers and developers increasingly seek tailored mRNA sequences that can be optimized for specific therapeutic outcomes, such as improved protein expression or enhanced immune response.

"The Asia Pacific region is growing at the highest CAGR in the mRNA synthesis and manufacturing market from 2024 to 2029."

The mRNA synthesis and manufacturing market is segmented into six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is the fastest-growing regional segment in the global mRNA synthesis and manufacturing market, Factors such as rising healthcare expenditure; growing R&D expansion in key markets such as India, China, and Japan; low labor costs; and the favorable regulatory environment in the region are expected to contribute to market growth. China's mRNA synthesis and manufacturing market is driven by the country's substantial government investments in biotech innovation, rapid expansion of domestic biotech infrastructure, and increasing international collaborations. In recent developments, China has demonstrated a strong commitment to advancing mRNA technology.

The primary interviews conducted for this report can be categorized as follows:

List of Companies Profiled in the Report:

Research Coverage:

This research report categorizes the mRNA synthesis and manufacturing market by Product (transcription consumables, purification consumables, analysis & characterization consumables, and instrument), Application (cell and gene therapy, vaccine, and other applications), End User (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs) and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the mRNA synthesis and manufacturing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, service portfolio, key strategies such as collaborations, partnerships, expansions, agreements, and acquisitions, and recent developments associated with the mRNA synthesis and manufacturing market. Competitive analysis of top players and upcoming startups in the mRNA synthesis and manufacturing market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall mRNA synthesis and manufacturing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT

7 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION

8 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER

9 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE

10 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER

11 MRNA SYNTHESIS & MANUFACTURING MARKET, BY REGION

13 COMPANY PROFILES

14 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â